Biora Therapeutics Inc (BIOR) Stock
BIOR is no longer traded. Biora Therapeutics was delisted from the Nasdaq in December 2024.
Prices on this page are historical; the last trade was December 30, 2024 at $0.22.
Biora Therapeutics stock price history
BIOR final trading statistics
- Final close
- $0.22
- Final trading day
- Dec 30, 2024
- Market cap at delisting
- $995.0K
- Shares outstanding
- 4.52M
- Final 52-week range
- $0.15 – $5.69
- Avg. volume (final 3 mo.)
- 137,312
- All-time high (split-adj.)
- $3280.00 · Jun 2020
- All-time low (split-adj.)
- $0.22 · Dec 2024
- Return since IPO
- -100.0%
- Beta
- 1.28
- Book value / share
- -$36.43
- Price / book
- -0.01
Biora Therapeutics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $4.0K | -$124.1M | -$8.57 |
| FY2022 | $305.0K | -$38.2M | -$5.14 |
| FY2021 | $1.25M | -$178.5M | -$55.75 |
| FY2020 | $74.31M | -$192.5M | -$221.32 |
| FY2019 | $143.99M | -$148.0M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Biora Therapeutics Inc
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. On December 27, 2024, Biora Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Biora Therapeutics stock FAQ
What happened to Biora Therapeutics stock?
Biora Therapeutics stock was delisted from the Nasdaq. Its final close was $0.22 on December 30, 2024.
Is BIOR stock still trading?
No. BIOR was delisted from the Nasdaq in December 2024 and no longer trades on a U.S. exchange.
What was the last price of BIOR stock?
BIOR closed at $0.22 on its final trading day, December 30, 2024, for a market value of about $995.0K.
What were Biora Therapeutics's revenue and earnings in its last full fiscal year?
Biora Therapeutics reported revenue of $4.0K and net income of -$124.1M in fiscal 2023, its last full year as a public company.
When did Biora Therapeutics go public?
Biora Therapeutics Inc stock began trading on June 19, 2020.